Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy

Daniel O. Claassen, Val Lowe, Patrick J. Peller, Ronald Carl Petersen, Keith Anthony Josephs

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Multiple Systems Atrophy (MSA) and Dementia with Lewy bodies (DLB) can present with both REM behavior disorder and severe autonomic dysfunction. In rare occasions, patients with MSA progress to cognitive impairment and even dementia. Positron emission topography (PET) imaging using both the amyloid ligand Pittsburgh Compound B (11C-PiB) and 18 flurodeoxyglucose (18F-FDG) was used to ascertain the presence of amyloid and pattern of glucose metabolic derangement in both disorders. Methods: Patients diagnosed with probable DLB or MSA, with clinical symptoms of either REM Behavior Disorder (RBD), Parkinsonism, or dysautonomia were prospectively identified. All underwent both 11C-PiB and 18F-FDG PET imaging. Statistical comparison between DLB, MSA, and normal controls was performed. Results: Six patients, 3 with DLB, 2 with Parkinson predominant MSA (MSA-P), and 1 with cerebellar predominant MSA (MSA-C) were identified. Increased level of PiB retention was noted in all patients diagnosed with DLB, but was absent in MSA. In those with DLB, glucose hypometabolism corresponded with regions of amyloid presence, and included prefrontal, parietotemporal, occipital and primary visual cortex regions. MSA patients were distinguished by cerebellar glucose hypometabolism. Conclusions: These findings emphasize the distinguishing characteristics between the alpha-synuclein related disorders of DLB and MSA. The absence of amyloid in the cases of MSA is a possible distinguishing characteristic of the disorder.

Original languageEnglish (US)
Pages (from-to)160-165
Number of pages6
JournalParkinsonism and Related Disorders
Volume17
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Multiple System Atrophy
Lewy Body Disease
Amyloid
Glucose
REM Sleep Behavior Disorder
Fluorodeoxyglucose F18
Primary Dysautonomias
Electrons
alpha-Synuclein
Parkinsonian Disorders
Visual Cortex
Dementia

Keywords

  • Autonomic diseases
  • Dementia with Lewy bodies
  • Multiple system atrophy
  • Parasomnias
  • PIB PET

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy. / Claassen, Daniel O.; Lowe, Val; Peller, Patrick J.; Petersen, Ronald Carl; Josephs, Keith Anthony.

In: Parkinsonism and Related Disorders, Vol. 17, No. 3, 03.2011, p. 160-165.

Research output: Contribution to journalArticle

@article{892eea7fb45e44009b6d7c6263bb4751,
title = "Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy",
abstract = "Background: Multiple Systems Atrophy (MSA) and Dementia with Lewy bodies (DLB) can present with both REM behavior disorder and severe autonomic dysfunction. In rare occasions, patients with MSA progress to cognitive impairment and even dementia. Positron emission topography (PET) imaging using both the amyloid ligand Pittsburgh Compound B (11C-PiB) and 18 flurodeoxyglucose (18F-FDG) was used to ascertain the presence of amyloid and pattern of glucose metabolic derangement in both disorders. Methods: Patients diagnosed with probable DLB or MSA, with clinical symptoms of either REM Behavior Disorder (RBD), Parkinsonism, or dysautonomia were prospectively identified. All underwent both 11C-PiB and 18F-FDG PET imaging. Statistical comparison between DLB, MSA, and normal controls was performed. Results: Six patients, 3 with DLB, 2 with Parkinson predominant MSA (MSA-P), and 1 with cerebellar predominant MSA (MSA-C) were identified. Increased level of PiB retention was noted in all patients diagnosed with DLB, but was absent in MSA. In those with DLB, glucose hypometabolism corresponded with regions of amyloid presence, and included prefrontal, parietotemporal, occipital and primary visual cortex regions. MSA patients were distinguished by cerebellar glucose hypometabolism. Conclusions: These findings emphasize the distinguishing characteristics between the alpha-synuclein related disorders of DLB and MSA. The absence of amyloid in the cases of MSA is a possible distinguishing characteristic of the disorder.",
keywords = "Autonomic diseases, Dementia with Lewy bodies, Multiple system atrophy, Parasomnias, PIB PET",
author = "Claassen, {Daniel O.} and Val Lowe and Peller, {Patrick J.} and Petersen, {Ronald Carl} and Josephs, {Keith Anthony}",
year = "2011",
month = "3",
doi = "10.1016/j.parkreldis.2010.12.006",
language = "English (US)",
volume = "17",
pages = "160--165",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy

AU - Claassen, Daniel O.

AU - Lowe, Val

AU - Peller, Patrick J.

AU - Petersen, Ronald Carl

AU - Josephs, Keith Anthony

PY - 2011/3

Y1 - 2011/3

N2 - Background: Multiple Systems Atrophy (MSA) and Dementia with Lewy bodies (DLB) can present with both REM behavior disorder and severe autonomic dysfunction. In rare occasions, patients with MSA progress to cognitive impairment and even dementia. Positron emission topography (PET) imaging using both the amyloid ligand Pittsburgh Compound B (11C-PiB) and 18 flurodeoxyglucose (18F-FDG) was used to ascertain the presence of amyloid and pattern of glucose metabolic derangement in both disorders. Methods: Patients diagnosed with probable DLB or MSA, with clinical symptoms of either REM Behavior Disorder (RBD), Parkinsonism, or dysautonomia were prospectively identified. All underwent both 11C-PiB and 18F-FDG PET imaging. Statistical comparison between DLB, MSA, and normal controls was performed. Results: Six patients, 3 with DLB, 2 with Parkinson predominant MSA (MSA-P), and 1 with cerebellar predominant MSA (MSA-C) were identified. Increased level of PiB retention was noted in all patients diagnosed with DLB, but was absent in MSA. In those with DLB, glucose hypometabolism corresponded with regions of amyloid presence, and included prefrontal, parietotemporal, occipital and primary visual cortex regions. MSA patients were distinguished by cerebellar glucose hypometabolism. Conclusions: These findings emphasize the distinguishing characteristics between the alpha-synuclein related disorders of DLB and MSA. The absence of amyloid in the cases of MSA is a possible distinguishing characteristic of the disorder.

AB - Background: Multiple Systems Atrophy (MSA) and Dementia with Lewy bodies (DLB) can present with both REM behavior disorder and severe autonomic dysfunction. In rare occasions, patients with MSA progress to cognitive impairment and even dementia. Positron emission topography (PET) imaging using both the amyloid ligand Pittsburgh Compound B (11C-PiB) and 18 flurodeoxyglucose (18F-FDG) was used to ascertain the presence of amyloid and pattern of glucose metabolic derangement in both disorders. Methods: Patients diagnosed with probable DLB or MSA, with clinical symptoms of either REM Behavior Disorder (RBD), Parkinsonism, or dysautonomia were prospectively identified. All underwent both 11C-PiB and 18F-FDG PET imaging. Statistical comparison between DLB, MSA, and normal controls was performed. Results: Six patients, 3 with DLB, 2 with Parkinson predominant MSA (MSA-P), and 1 with cerebellar predominant MSA (MSA-C) were identified. Increased level of PiB retention was noted in all patients diagnosed with DLB, but was absent in MSA. In those with DLB, glucose hypometabolism corresponded with regions of amyloid presence, and included prefrontal, parietotemporal, occipital and primary visual cortex regions. MSA patients were distinguished by cerebellar glucose hypometabolism. Conclusions: These findings emphasize the distinguishing characteristics between the alpha-synuclein related disorders of DLB and MSA. The absence of amyloid in the cases of MSA is a possible distinguishing characteristic of the disorder.

KW - Autonomic diseases

KW - Dementia with Lewy bodies

KW - Multiple system atrophy

KW - Parasomnias

KW - PIB PET

UR - http://www.scopus.com/inward/record.url?scp=79951553759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951553759&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2010.12.006

DO - 10.1016/j.parkreldis.2010.12.006

M3 - Article

VL - 17

SP - 160

EP - 165

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 3

ER -